The Group's principal activity is the procurement, manufacture, preparation and sale of Therapeutic products especially haemoderivatives. The Group operates through its four divisions. Bioscience Division: Specializes in the development of high quality plasma derivatives; Diagnostic Division: focuses on developing 'in vitro' diagnostic products for laboratory; Hospital Division: provides a wide range of non-biological products used in hospital; Material Division: sales of Intermediate products and the rendering of manufacturing services to third artiest. The Group had its operations in European Union, North America and Latin America.
Alacra Alerts:
Receive alerts on the latest reports on Grifols S.A.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
